Keeps Biopharma Inc. (KOSDAQ:256940)

Keeps Biopharma Revenue

Keeps Biopharma had revenue of 74.88B KRW in the quarter ending June 30, 2026, with 72.77% growth. This brings the company's total for the last twelve months to 220.48B, up 48.61% year-over-year. In the year 2025, Keeps Biopharma had annual revenue of 170.15B with 33.36% growth. That makes Keeps Biopharma the 18,813th largest company in the world by revenue and 974th in South Korea.

• Revenue (ttm): 220.48B
• Revenue Growth: +48.61%
• P/S Ratio: 0.50
• Revenue / Employee: 1.71B
• Employees: 129
• Market Cap: 110.83B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Recycling 115.61B 66.8%
• Bio Business Division 49.22B 28.4%
• OLED Business 8.35B 4.8%

By Geography

Chart

• South Korea 166.64B 97.9%
• China 2.91B 1.7%
• Japan 600.00M 0.4%

Fiscal year ended Dec 31, 2025 See the full Keeps Biopharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	170.15B	42.56B	33.36%
Dec 31, 2024	127.58B	35.45B	38.48%
Dec 31, 2023	92.13B	77.52B	530.30%
Dec 31, 2022	14.62B	10.36B	243.08%
Dec 31, 2021	4.26B	-10.96B	-72.00%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error